Skip to main content

Rates of Dissatisfaction High for Hidradenitis Suppurativa Care

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2025.

via HealthDay

MONDAY, April 7, 2025 -- The rates of respondent dissatisfaction with current hidradenitis suppurativa (HS) treatment options are high, likely due to undertreatment with available therapies, according to study published in the April issue of the Journal of Drugs in Dermatology.

Andeulazia Murdock, from the George Washington School of Medicine and Health Sciences in Washington, D.C., and colleagues distributed a survey to examine perceptions of current and emerging HS treatments and their impact on quality of life among respondents aged 18 years and older. Overall, 423 participants completed the entire survey.

The researchers found that <20 percent of respondents (76/423) were satisfied or very satisfied with current treatment options. Only 39 and/or 26 percent of the 244 patients with self-reported disease severity of Hurley stage II or III were being treated with biologics and/or hormone therapy, respectively, indicating undertreatment per current guidelines. Seventy-four percent of the respondents were unaware of U.S. Food and Drug Administration-approved treatments; more than half (56 percent) reported that these options had not been discussed by their dermatologist or health care provider. Sixty percent of respondents felt it was important to have FDA-approved therapies, believing it would result in improved physical health, mental health, and/or personal relationships (86, 78, and 60 percent, respectively).

"Our goal with this study was to highlight the multifaceted positive impact of new FDA treatments on those living with hidradenitis and the importance of pharma investment in this space," coauthor Adam Friedman, M.D., also from the George Washington School of Medicine and Health Sciences, said in a statement. "We also found that there are still significant gaps in care and dissatisfaction with current treatment approaches."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Dietary Patterns Influence Development of Overactive Bladder

FRIDAY, June 20, 2025 -- Dietary patterns influence the development of overactive bladder (OAB), according to a study published online May 12 in Frontiers of Nutrition. Yiming...

Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma

FRIDAY, June 20, 2025 -- Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study published online June 18 in JAMA...

Tinnitus Linked to Impaired Cognitive Function

FRIDAY, June 20, 2025 -- Individuals with versus those without tinnitus have significantly lower scores on cognitive function tests, according to a study published online May 29...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.